New evidence shows that extended estrogen suppression treatment using an aromatase inhibitors for hormone receptor-positive postmenopausal breast cancer is safe; it does not increase the risk of ...

A treatment known as ovarian suppression used along with an anti-estrogen drug normally given to older women appears to greatly reduce the risk of breast cancer recurrence in some younger women, new ...